Zobrazeno 1 - 10
of 148
pro vyhledávání: '"M A, Rich"'
Autor:
S. B. Patil, M. Tamirat, K. Khazhidinov, E. Ardizzoni, M. Atger, A. Austin, E. Baudin, M. Bekhit, S. Bektasov, E. Berikova, M. Bonnet, R. Caboclo, M. Chaudhry, V. Chavan, S. Cloez, J. Coit, S. Coutisson, Z. Dakenova, B. C. De Jong, C. Delifer, S. Demaisons, J. M. Do, D. Dos Santos Tozzi, V. Ducher, G. Ferlazzo, M. Gouillou, U. Khan, M. Kunda, N. Lachenal, A. N. LaHood, L. Lecca, M. Mazmanian, H. McIlleron, M. Moreau, M. Moschioni, P. Nahid, E. Osso, L. Oyewusi, S. Panda, A. Pâquet, P. Thuong Huu, L. Pichon, M. L. Rich, P. Rupasinghe, N. Salahuddin, E. Sanchez Garavito, K. J. Seung, G. E. Velásquez, M. Vallet, F. Varaine, F. J. Yuya-Septoh, C. D. Mitnick, L. Guglielmetti
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-14 (2023)
Abstract Background Treatment for fluoroquinolone-resistant multidrug-resistant/rifampicin-resistant tuberculosis (pre-XDR TB) often lasts longer than treatment for less resistant strains, yields worse efficacy results, and causes substantial toxicit
Externí odkaz:
https://doaj.org/article/2bb066dc17d74fc58700a32bcf0b5485
Autor:
L. Guglielmetti, E. Ardizzoni, M. Atger, E. Baudin, E. Berikova, M. Bonnet, E. Chang, S. Cloez, J. M. Coit, V. Cox, B. C. de Jong, C. Delifer, J. M. Do, D. Dos Santos Tozzi, V. Ducher, G. Ferlazzo, M. Gouillou, A. Khan, U. Khan, N. Lachenal, A. N. LaHood, L. Lecca, M. Mazmanian, H. McIlleron, M. Moschioni, K. O’Brien, O. Okunbor, L. Oyewusi, S. Panda, S. B. Patil, P. P. J. Phillips, L. Pichon, P. Rupasinghe, M. L. Rich, N. Saluhuddin, K. J. Seung, M. Tamirat, L. Trippa, M. Cellamare, G. E. Velásquez, S. Wasserman, P. J. Zimetbaum, F. Varaine, C. D. Mitnick
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-15 (2021)
Abstract Background Treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR-TB) is expensive, labour-intensive, and associated with substantial adverse events and poor outcomes. While most MDR/RR-TB patients do not receive treatment, many
Externí odkaz:
https://doaj.org/article/85bd589a0cd64486abc5fda915c2f7c5
Autor:
M. L. Rich, U. Khan, C. Zeng, A. LaHood, M. F. Franke, S. Atwood, M. Bastard, E. Burhan, N. Danielyan, P. M. Dzhazibekova, D. Gadissa, A. Ghafoor, C. Hewison, M. S. Islam, E. Kazmi, P. Y. Khan, L. Lecca, L. B. Maama, N. Melikyan, Y. Y. Naing, K. Philippe, N. A. Saki, K. J. Seung, A. Skrahina, G. B. Tefera, F. Varaine, S. C. Vilbrun, L. Võ, C. D. Mitnick, H. Huerga, null on behalf of the endTB Observational Study Te
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 27:451-457
BACKGROUND: Evidence of the effectiveness of the WHO-recommended design of longer individualized regimens for multidrug- or rifampicin-resistant TB (MDR/RR-TB) is limited.OBJECTIVES: To report end-of-treatment outcomes for MDR/RR-TB patients from a 2
Autor:
C. Zeng, C. D. Mitnick, C. Hewison, M. Bastard, P. Khan, K. J. Seung, M. L. Rich, S. Atwood, N. Melikyan, N. Morchiladze, N. Khachatryan, M. Khmyz, C. G. Restrepo, N. Salahuddin, E. Kazmi, A. A. Dahri, S. Ahmed, F. Varaine, S. C. Vilbrun, L. Oyewusi, A. Gelin, K. Tintaya, L. T. Yeraliyeva, S. Hamid, U. Khan, H. Huerga, M. F. Franke
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 27:34-40
BACKGROUND: The WHO provides standardized outcome definitions for rifampicin-resistant (RR) and multidrug-resistant (MDR) TB. However, operationalizing these definitions can be challenging in some clinical settings, and incorrect classification may g
Gene editing in C. elegans using plasmid-based CRISPR reagents requires microinjection of many animals to produce a single edit. Germline silencing of plasmid-borne Cas9 is a major cause of inefficient editing. Here, we present a set of C. elegans st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88199e7f55e2c0427c81dcbd9a317c4d
https://doi.org/10.1101/2021.08.03.454883
https://doi.org/10.1101/2021.08.03.454883
Autor:
Stephen A. Spates, David Westerman, Kyle B. Heuett, Katie M. Reno-Rich, Catherine Y. Kingsley Westerman
Publikováno v:
Communication Research Reports. 36:287-297
This study investigated preference for delivering feedback, including preferred channels, degree of privacy, and degree of synchronicity. Participants were asked to rate their preferences for vario...
Autor:
Marieke M. L. Rich, Jurriaan H. de Groot, J.H. Arendzen, Jasper Schuurmans, Alfred C. Schouten, Carel G. M. Meskers
Publikováno v:
Experimental Brain Research, 201(4), 681-688. Springer Verlag
Experimental Brain Research. Experimentelle Hirnforschung. Experimentation Cerebrale
Experimental Brain Research, 201(4), 681-688
Meskers, C G M, Schouten, A C, Rich, M M L, De Groot, J H, Schuurmans, J & Arendzen, J H 2010, ' Tizanidine does not affect the linear relation of stretch duration to the long latency M2 response of m. flexor carpi radialis ', Experimental Brain Research, vol. 201, no. 4, pp. 681-688 . https://doi.org/10.1007/s00221-009-2085-x
Experimental brain research, 201 (4), 2010
Experimental brain research, 201(4), 681-688. Springer
Experimental Brain Research, 201(4), 681-8
Experimental Brain Research. Experimentelle Hirnforschung. Experimentation Cerebrale
Experimental Brain Research, 201(4), 681-688
Meskers, C G M, Schouten, A C, Rich, M M L, De Groot, J H, Schuurmans, J & Arendzen, J H 2010, ' Tizanidine does not affect the linear relation of stretch duration to the long latency M2 response of m. flexor carpi radialis ', Experimental Brain Research, vol. 201, no. 4, pp. 681-688 . https://doi.org/10.1007/s00221-009-2085-x
Experimental brain research, 201 (4), 2010
Experimental brain research, 201(4), 681-688. Springer
Experimental Brain Research, 201(4), 681-8
The long latency M2 electromyographic response of a suddenly stretched active muscle is stretch duration dependent of which the nature is unclear. We investigated the influence of the group II afferent blocker tizanidine on M2 response characteristic
Autor:
Wayne Katon, Julie R. Gralow, Jesse R. Fann, Deborah S. Cowley, Mary Pepping, Bonnie A. McGregor, Anne M. Thomas-Rich
Publikováno v:
General Hospital Psychiatry. 30:112-126
Objective While many breast cancer patients experience “normal” distress, there is a subset who experience clinically significant depression. We examined the current knowledge about the prevalence, impact and treatment of major depression in wome